Pay in 4 interest-free payments of $6.67 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Curr Diabetes Rev (2023) 19(7):e141122210875
This handling guidance pertains solely to preserving analytical integrity in the laboratory and does not imply any route of administration
Patients with clinical presentation suspicious for NF1 or NF2 should be referred for neurologic and developmental evaluation (see chapter 6)
The CCA for the remaining meta-analyses was 20.83%, indicating a very high level of overlap
US$ 27.87
US$ 25.09
US$ 28.94
US$ 20.67
US$ 21.08
US$ 20.38
US$ 21.94
US$ 26.48
US$ 21.44
US$ 21.66
US$ 21.36
